XML 69 R84.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Equity and Cash Incentive Program (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Shares available for grant 17,000,000    
Vesting period (in years) 3 years    
Award term 10 years    
Additional Disclosures [Abstract]      
Tax benefit from the exercise of share-based awards $ 14,759 $ 8,365 $ 4,964
Stock-based compensation expense [Abstract]      
Pre-tax compensation expense 29,702 23,698 24,073
Tax benefit (2,490) (2,722) (8,411)
Total stock-based compensation expense, net of tax $ 27,212 $ 20,976 $ 15,662
Shares Granted to Directors [Abstract]      
Aggregate shares granted 10,838 15,802 16,231
Shares deferred (6,168) (9,917) (11,337)
Net shares granted 4,670 5,885 4,894
Stock Appreciation Rights (SARs) [Member]      
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Additional awards issued due to modification   1,138,008  
Risk-free interest rate (in hundredths) 2.51%   1.80%
Dividend yield (in hundredths) 2.13%   2.27%
Expected life (in years) 5 years 7 months 6 days   4 years 7 months 6 days
Volatility (in hundredths) 22.35%   21.90%
Grant price $ 91.20   $ 66.85
Fair value on date of grant 17.55   $ 10.65
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value $ 91.24    
Awards Outstanding [Roll Forward]      
Awards Outstanding (in number of shares) 3,599,169 5,329,204  
Awards Forfeit and Expired (in number of shares) (181,498)    
Awards Exercised (in number of shares) (2,163,626)    
Awards Exercisable (in number of shares) 1,579,082    
Awards Outstanding, Weighted Average Exercise Price [Roll Forward]      
Awards Outstanding, Weighted Average Exercise Price $ 69.07 $ 60.19  
Awards Forfeit and Expired, Weighted Average Exercise Price 78.84    
Awards Exercised, Weighted Average Exercise Price 52.66    
Awards Exercisable, Weighted Average Exercise Price $ 57.26    
Additional Disclosures [Abstract]      
Awards Outstanding, Weighted Average Remaining Contractual Term 6 years 4 months 24 days    
Awards Exercisable, Weighted Average Remaining Contractual Term 4 years 3 months 18 days    
Fair value of stock appreciation rights which became exerciable during the year $ 8,611 $ 12,832 $ 16,006
Awards Exercised, Total Intrinsic Value $ 89,473 $ 101,365 $ 44,646
Unvested Awards [Roll Forward]      
Awards Granted (in number of shares) 615,089 757,603 1,028,116
Unrecognized Compensation Cost [Abstract]      
Unrecognized Compensation Expense $ 8,862    
Unrecognized Compensation Expense, Period for Recognition 1 year 8 months 12 days    
Performance Shares [Member]      
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Additional awards issued due to modification   26,316  
Grant price $ 91.33    
Fair value on date of grant 91.20   $ 66.85
Awards Outstanding, Weighted Average Exercise Price [Roll Forward]      
Awards Forfeit and Expired, Weighted Average Exercise Price $ 76.46    
Unvested Awards [Roll Forward]      
Awards Unvested (in number of shares) 137,809 144,957  
Awards Granted (in number of shares) 35,172 122,459 57,958
Awards Forfeit (in number of shares) (19,026)    
Awards Vested (in number of shares) (23,294)    
Unvested Awards, Weighted Average Grant Date Fair Value [Roll Forward]      
Awards Unvested, Weighted Average Grant Date Fair Value $ 82.45 $ 76.99  
Awards Vested, Weighted Average Grant Date Fair Value $ 66.85    
Unrecognized Compensation Cost [Abstract]      
Unrecognized Compensation Expense $ 13,016    
Unrecognized Compensation Expense, Period for Recognition 1 year 3 months 18 days    
Shares Granted to Directors [Abstract]      
Performance Share Attainment 200.30% 282.40% 237.00%
Restricted Stock Units (RSUs) [Member]      
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Additional awards issued due to modification   47,063  
Fair value on date of grant $ 91.34    
Unvested Awards [Roll Forward]      
Awards Unvested (in number of shares) 324,553 390,481  
Awards Granted (in number of shares) 124,929 284,721 174,203
Awards Forfeit (in number of shares) (23,706)    
Awards Vested (in number of shares) (167,151)    
Unvested Awards, Weighted Average Grant Date Fair Value [Roll Forward]      
Awards Unvested, Weighted Average Grant Date Fair Value $ 81.45 $ 73.35  
Awards Forfeit, Weighted Average Grant Date Fair Value 84.02    
Awards Vested, Weighted Average Grant Date Fair Value $ 69.55    
Unrecognized Compensation Cost [Abstract]      
Unrecognized Compensation Expense $ 17,307    
Unrecognized Compensation Expense, Period for Recognition 1 year 7 months 6 days    
Minimum [Member] | Stock Appreciation Rights (SARs) [Member]      
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Risk-free interest rate (in hundredths)   2.58%  
Dividend yield (in hundredths)   1.99%  
Expected life (in years)   5 years 7 months 6 days  
Volatility (in hundredths)   20.95%  
Grant price   $ 79.75  
Fair value on date of grant   14.58  
Minimum [Member] | Performance Shares [Member]      
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Fair value on date of grant   $ 79.75  
Maximum [Member] | Stock Appreciation Rights (SARs) [Member]      
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Risk-free interest rate (in hundredths)   2.87%  
Dividend yield (in hundredths)   2.43%  
Expected life (in years)   5 years 8 months 12 days  
Volatility (in hundredths)   21.20%  
Grant price   $ 82.09  
Fair value on date of grant   15.41  
Maximum [Member] | Performance Shares [Member]      
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Fair value on date of grant   $ 82.09  
Discontinued Operations [Member]      
Stock-based compensation expense [Abstract]      
Pre-tax compensation expense   $ 744 $ 2,454